Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Total Debt (2016 - 2025)

Immucell's Total Debt history spans 16 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Total Debt fell 13.66% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, down 13.66%, while the annual FY2025 figure was $9.1 million, 13.66% down from the prior year.
  • Total Debt reached $9.1 million in Q4 2025 per ICCC's latest filing, down from $9.5 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $12.3 million in Q3 2023 to a low of $9.1 million in Q4 2025.
  • Average Total Debt over 5 years is $10.3 million, with a median of $10.2 million recorded in 2022.
  • Peak YoY movement for Total Debt: rose 17.55% in 2023, then decreased 13.66% in 2025.
  • A 5-year view of Total Debt shows it stood at $9.1 million in 2021, then increased by 11.94% to $10.2 million in 2022, then rose by 17.0% to $12.0 million in 2023, then fell by 11.95% to $10.5 million in 2024, then decreased by 13.66% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Total Debt are $9.1 million (Q4 2025), $9.5 million (Q3 2025), and $9.8 million (Q2 2025).